Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Aug 31;17(8):e0273532. doi: 10.1371/journal.pone.0273532

Retraction: Integrative bioinformatics approaches to map key biological markers and therapeutic drugs in Extramammary Paget’s disease of the scrotum

The PLOS ONE Editors
PMCID: PMC9432758  PMID: 36044437

The PLOS ONE Editors retract this article [1, 2] because it was identified as one of a series of submissions for which we have concerns about authorship, competing interests, and peer review. We regret that the issues were not addressed prior to the article’s publication.

All authors did not agree with the retraction.

References

  • 1.Noor F, Saleem MH, Chen J-T, Javed MR, Al-Megrin WA, Aslam S (2021) Integrative bioinformatics approaches to map key biological markers and therapeutic drugs in Extramammary Paget’s disease of the scrotum. PLoS ONE 16(7): e0254678. 10.1371/journal.pone.0254678 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 2.Noor F, Saleem MH, Chen J-T, Javed MR, Al-Megrin WA, Aslam S (2021) Correction: Integrative bioinformatics approaches to map key biological markers and therapeutic drugs in Extramammary Paget’s disease of the scrotum. PLoS ONE 16(10): e0259408. 10.1371/journal.pone.0259408 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES